The Enterprise Value as of December 2025 (TTM) for ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK) is 1.97B

According to ImmuneOnco Biopharmaceuticals (Shanghai) Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.97B. This represents a change of -61.11% compared to the average of 5.07B of the last 4 quarters.

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK) Historical Enterprise Value (quarterly & annually)

How has 1541.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. over the last ten years is 5.54B. The current 1.97B Enterprise Value has changed 3.46% with respect to the historical average. Over the past ten years (40 quarters), 1541.HK's Enterprise Value was at its highest in in the December 2023 quarter at 9.90B. The Enterprise Value was at its lowest in in the December 2024 quarter at 1.50B.

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK) Average Enterprise Value

How has 1541.HK Enterprise Value performed in the past?

The current Enterprise Value of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK) Enterprise Value vs. Peers

How is 1541.HK’s Enterprise Value compared to its peers?

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.’s Enterprise Value is greater than Antengene Corporation Limited (1.68B), less than Jiangsu Recbio Technology Co., Ltd. (2.93B), less than Clover Biopharmaceuticals, Ltd. (2.59B), less than Hua Medicine (Shanghai) Ltd. (2.03B), greater than Cutia Therapeutics (1.58B), less than Medtide Inc. (0), greater than SinoMab BioScience Limited (1.92B), greater than OrbusNeich Medical Group Holdings Limited (149.51M), less than AIM Vaccine Co., Ltd. (5.30B), greater than HighTide Therapeutics Inc (1.24B),

Build a custom stock screener for ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmuneOnco Biopharmaceuticals (Shanghai) Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmuneOnco Biopharmaceuticals (Shanghai) Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.